Why is Injective price up today?

Traders Union
All News
Crypto
Injective surges 10.55% today to $3.80

Highlights

INJ/USD is in a short-term bullish phase, trading above key short-term averages but below major long-term resistance.
Momentum indicators confirm buyer control and strong upward movement, though no signs of exhaustion or overbought pressure are present.
Expected price range for the next five days is $3.58–$3.95, with sideways action favored unless $3.95 or $3.58 levels are breached.

Anton Kharitonov, expert at Traders Union, points out that Injective (INJ) shows only temporary strength above short-term moving averages while still trading well below the 200-day average. He cautions that the absence of any meaningful news diminishes market conviction and increases the risk of mean reversion. Kharitonov views the current bullish momentum as likely to fade quickly, especially given that key weekly indicators remain neutral or negative. The analyst sees limited fundamental drivers to support a sustained rally and warns of downside risks if $3.58 fails. "Investors should act cautiously, as momentum is shallow and the long-term bearish structure remains untouched," he advises.

Viktoras Karapetjanc, expert at Traders Union, maintains a constructive view on INJ’s current technical formations. He sees that the asset’s close above both the 20- and 50-day averages underlines solid buyer control, supporting a bullish foundation. Despite the short-term nature of the move, Karapetjanc believes the setup offers further growth potential if $3.95 is cleared. He notes that strong intraday momentum creates new opportunities for active traders in the coming days. "The bullish structure remains intact, and a break of $4.00 could unlock further upward moves," he states.

Parshwa Turakhiya, analyst, observes that sentiment has turned positive for INJ as buyers dominate the current price action. He notes that volatility and upward gaps provide tactical setups for short-term trades, especially with key indicators yet to reach overbought levels. Turakhiya sees sideways movement as the baseline case but highlights the defined price corridor as a creative space for range strategies. "With strong momentum and clear levels, short-term players can capitalize on quick price swings between $3.58 and $3.95," he says.

Momentum strengthens as dynamic support meets resistance zone

INJ/USD is trading above the 20-day ($3.35) and 50-day ($3.12) moving averages, but well below the 200-day ($4.70), reflecting a short-term bullish setup with longer-term resistance still intact. The Kijun line from the Ichimoku indicator at $3.49 serves as dynamic support, while the next resistance is near the $4.00 round level.

Momentum signals from the Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) on the daily chart are positive, indicating buyers are in control. The Relative Strength Index (RSI) and Commodity Channel Index (CCI) are not in overbought territory, while Stochastic RSI suggests strong upward momentum. Bull/Bear Power (BBP) is above zero, signaling buyer dominance. The Awesome Oscillator is neutral, providing no additional confirmation. The pair opened with an upside gap of about $0.21 and is currently near the top of the day’s range after rising 10.55% to $3.80. Intraday volatility stands at 4.12%, reflecting strength toward the highs. The strong daily momentum is confirmed by supporting signals from the main indicators.

Earlier, analysts noted that despite short-term momentum in Injective overbought signals and longer-term resistance warranted caution for traders. Fresh momentum readings now reinforce a cautiously constructive outlook, with traders advised to monitor the $3.95 level as a potential pivot for renewed upside or reversal risk.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.